InMode Ltd.

InMode Ltd. Q2 2025 Earnings Recap

INMD Q2 2025 August 1, 2025

Get alerts when INMD reports next quarter

Set up alerts — free

InMode reported Q2 2025 revenues of $95.6 million, representing a year-over-year increase while navigating a challenging medical aesthetic market, particularly in North America.

Earnings Per Share Beat
$0.47 vs $0.43 est.
+9.3% surprise
Revenue Miss
95602000 vs 98447210 est.
-2.9% surprise

Market Reaction

1-Day +2.4%
5-Day +2.69%
30-Day +5.6%

See INMD alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Revenues increased 10% year-over-year, despite a decline in capital spending by physicians.
  • Sales outside the U.S. rose to $45 million, accounting for 48% of total revenue, with Europe as a key growth driver.
  • Non-GAAP diluted EPS increased 38% to $0.47, reflecting strong operational efficiency with a gross margin of 80%.
  • The company plans to restructure its sales team and expand directly into new markets, including Thailand and Argentina to enhance customer engagement.
  • Guidance for 2025 adjusted to $365-$375 million in revenue, indicating cautious optimism amid ongoing macroeconomic headwinds.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit INMD on AllInvestView.

Get the Full Picture on INMD

Track InMode Ltd. in your portfolio with real-time analytics, dividend tracking, and more.

View INMD Analysis